Heart transplant outcomes in patients with Chagas cardiomyopathy in the united states
from Clinical Transplantation
Chagas cardiomyopathy (CC) is one of the chronic manifestations of Trypanosoma cruzi (T. cruzi) infection and is among the leading reasons for heart transplantation (HT) in Latin America. Chagas disease is also present in areas with large Hispanic communities in the United States. Our objective is to evaluate the outcomes of cardiac allograft recipients with the diagnosis of CC in the United States.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063